A. Schneider et al., EFFICACY TRIAL OF TOPICALLY ADMINISTERED INTERFERON GAMMA-1-BETA GEL IN COMPARISON TO LASER TREATMENT IN CERVICAL INTRAEPITHELIAL NEOPLASIA, Archives of gynecology and obstetrics, 256(2), 1995, pp. 75-83
Objective: Dose dependent response of cervical intraepithelial neoplas
ia (GIN) to topically administered interferon (IFN) gamma was assessed
and compared with conventional laser therapy. Patient and methods: 33
women were included in a randomized phase II trial which was double b
linded for IFN dosages. Twenty-four patients received IFN gamma-1 beta
gel and a control group of nine patients was treated with laser surge
ry. 18 patients had smears suggesting CIN II and 15 patients had smear
s suggesting CIN III. The response was assessed 6 months after startin
g of IFN gamma-1 beta treatment or having laser surgery. Results: Topi
cal IFN gamma-1 beta treatment gave a cure rate of 42% independent of
IFN dosage as compared to an 89% cure rate with laser therapy (P=0.02)
. Patients with CIN II responded better compared with patients with CI
N III. Current smokers showed a significantly lower cure rate whereas
use of oral contraceptives (OC) did not influence response. High viral
load with high risk types of human papillomaviruses (HPV) was associa
ted with a better response.